CAPR

13.07

1.32% 0.17

시간 외 거래: 13.10 0.03 +0.23%

Capricor Therapeutics Inc (CAPR)

개요 뉴스 가격 이력 옵션 체인 Financials CAPR 왜 하락? 토론 예측 주식 분할

전일 마감가:

$12.90

열려 있는:

$12.64

하루 거래량:

5.46M

Relative Volume:

1.56

시가총액:

$594.29M

수익:

$27.10M

순이익/손실:

$-24.31M

주가수익비율:

-11.17

EPS:

-1.17

순현금흐름:

$-33.33M

1주 성능:

-1.43%

1개월 성능:

-30.92%

6개월 성능:

+174.58%

1년 성능:

+199.77%

1일 변동 폭

$12.57

$13.53

1주일 범위

$12.25

$14.50

52주 변동 폭

$3.52

$23.40

Capricor Therapeutics Inc Stock (CAPR) Company Profile

명칭

Capricor Therapeutics Inc

부문

Healthcare (1176)

산업

Biotechnology (673)

전화

(310) 358-3200

주소

8840 WILSHIRE BLVD, BEVERLY HILLS, CA

직원

102

트위터

@Capricor

다음 수익 날짜

2024-11-12

최신 SEC 제출 서류

CAPR's Discussions on Twitter

CAPR을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
CAPR Capricor Therapeutics Inc	13.07	594.29M	27.10M	-24.31M	-33.33M	-0.83
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-10-21	개시	Piper Sandler	Overweight
2024-05-17	개시	Oppenheimer	Outperform
2024-01-05	개시	Cantor Fitzgerald	Overweight
2022-10-26	개시	Ladenburg Thalmann	Buy
2018-12-26	다운그레이드	Maxim Group	Buy → Hold
2018-01-26	재확인	H.C. Wainwright	Buy
2017-09-15	재확인	H.C. Wainwright	Buy
2017-02-13	재개	Rodman & Renshaw	Buy
2016-07-06	재개	H.C. Wainwright	Buy
2016-06-15	개시	ROTH Capital	Buy

모두보기

Capricor Therapeutics Inc 주식(CAPR)의 최신 뉴스

Dec 20, 2024

(CAPR) Trading Advice - Stock Traders Daily

Dec 20, 2024

Dec 18, 2024

Capricor Therapeutics (CAPR) Stock Dips Amid Biotech Sector Decl - GuruFocus.com

Dec 18, 2024

Dec 16, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Update - MarketBeat

Dec 16, 2024

Dec 14, 2024

Capricor Therapeutics (NASDAQ:CAPR) Trading Down 5.3%Here's Why - MarketBeat

Dec 14, 2024

Dec 13, 2024

Capricor Therapeutics (CAPR) Stock Drops Amid Volatile Biotech Sector - GuruFocus.com

Dec 13, 2024

Dec 12, 2024

High Growth Tech Stocks To Watch In December 2024 - Simply Wall St

Dec 12, 2024

RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead - MarketWatch

Dec 12, 2024

Some Capricor Therapeutics, Inc. (NASDAQ:CAPR) Shareholders Look For Exit As Shares Take 27% Pounding - Simply Wall St

Dec 12, 2024

Dec 10, 2024

(CAPR) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Dec 10, 2024

Dec 09, 2024

250,204 Shares in Capricor Therapeutics Inc (NASDAQ:CAPR) Purchased by Point72 Asset Management L.P. - MarketBeat

Dec 09, 2024

Dec 07, 2024

Deramiocel's Promise Brightens Capricor's Outlook, With Strings Attached (NASDAQ:CAPR) - Seeking Alpha

Dec 07, 2024

Dec 06, 2024

Capricor: Additional Deramiocel Data Bodes Well For Initiated Rolling BLA Submission - Seeking Alpha

Dec 06, 2024

Dec 05, 2024

Jones Trading keeps $40 target on Capricor Therapeutics By Investing.com - Investing.com UK

Dec 05, 2024

Dec 03, 2024

Piper Sandler maintains $35 target on Capricor shares By Investing.com - Investing.com Canada

Dec 03, 2024

Dec 02, 2024

Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com

Dec 02, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Dec 02, 2024

Capricor Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

Dec 02, 2024

Capricor Therapeutics to Present at Major Healthcare Conferences in December | CAPR Stock News - StockTitan

Dec 02, 2024

Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail

Dec 02, 2024

Dec 01, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Receives $34.50 Average Price Target from Analysts - MarketBeat

Dec 01, 2024

Nov 27, 2024

Capricor Therapeutics (CAPR) Sees Stock Surge Amid Positive Anal - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

Pork Cutout (KMG25) Quote - The Globe and Mail

Nov 26, 2024

Nov 24, 2024

Capricor Therapeutics Executes Collaboration Agreement and Exclusive License Option with Janssen Biotech - Marketscreener.com

Nov 24, 2024

Nov 21, 2024

Capricor wins key EU designations for the lead asset - MSN

Nov 21, 2024

Nov 20, 2024

Capricor stock on watch after key EU designations (CAPR:NASDAQ) - Seeking Alpha

Nov 20, 2024

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency - The Manila Times

Nov 20, 2024

Nov 18, 2024

(CAPR) Proactive Strategies - Stock Traders Daily

Nov 18, 2024

Capricor Therapeutics shares rated Buy by Jones Trading, boosted by DMD-CM therapy - Investing.com Canada

Nov 18, 2024

What is HC Wainwright's Estimate for CAPR FY2024 Earnings? - MarketBeat

Nov 18, 2024

Nov 17, 2024

KBW Bank Index (BKX) QuotePress Release - The Globe and Mail

Nov 17, 2024

Nov 16, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Down 14.6% in October - MarketBeat

Nov 16, 2024

Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024